The use of fractional doses of yellow fever vaccine could reduce the amount of yellow fever vaccine for reactive campaigns and provide flexibility in management of global stockpile of yellow fever vaccine when outbreaks occur.
The estimated cumulative vaccine antigen exposure through age 23 months does not differ significantly for children with vs those without hospital visits for infectious diseases not targeted by vaccines from age 24 to 47 months.
Measles vaccination, administered in the recommended sequence, is associated with improved child survival and may have contribute to the achievement of Millennium Development Goal 4.
Behavioral interventions that include sexual risk reduction combined with alcohol- and cannabis-focused elements are effective in reducing STI incidence among adolescents.
Maternal receipt of influenza and tetanus toxoid, reduced diphtheria toxoid, and Tdap vaccines is not associated with infant hospitalization or death.
All formulations of a respiratory syncytial virus (RSV) candidate vaccine were able to boost RSV antibody titers and their safety profile was similar to the Tdap vaccine.
Newborns receiving the oral human neonatal rotavirus vaccine (RV3-BB) with the first dose occurring either at birth or at 8 weeks experienced fewer cases of severe rotavirus gastroenteritis than those treated with placebo.
Maternal vaccination against pertussis between 27 and 36 weeks of gestation was associated with a high percentage of newborns with protective pertussis antibody concentrations.
The FDA approval of Heplisav-B was based on data from 3 phase 3 noninferiority trials involving close to 10,000 adults who received the vaccine.
The Advisory Committee on Immunization Practices has provided 3 new recommendations to supplement its original 2008 report, as well as a cost-effectiveness analysis from the CDC.
A new study indicates that early-season influenza vaccination coverage was significantly higher among adults aged ≥18 years with a provider visit and recommendation/offer for vaccination.
No significant association was identified between maternal intrapartum vaccination with the influenza or tetanus, diphtheria, and acellular pertussis (Tdap) vaccine and infant hospitalization or mortality.
In the overall comparative meta-analyses, the multicomponent meningococcal serogroup B vaccine had increased immunogenicity (short-term and persistent) compared with recombinant meningococcal serogroup B vaccine against strain NZ98/254.
The ACIP has released the 2018 Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger.
The ACIP has released the 2018 Recommended Immunization Schedule for Adults Aged 19 Years or Older.
Patient reminder and recall systems seem to be effective for improving receipt of immunizations.
Prevention of severe and fatal infection caused by influenza was observed mainly in patients who were vaccinated in both the current and previous seasons, reinforcing the recommendation of annual vaccination in older adults.
Individuals who have previously received 2 doses of a mumps-containing vaccine should receive a third dose if at increased risk for developing mumps.
The Advisory Committee on Immunization Practices has issued updated recommendations for HBV prevention.
Providers may continue to offer vaccines until June 30 of every year, the date marking the end of the influenza season, because influenza is unpredictable.
At a price of $280 per series, the adjuvanted herpes zoster subunit vaccine would cost less than the live attenuated herpes zoster vaccine and has a high probability of offering good value.
A new expert guidance concerning contact precautions for multidrug resistant bacteria has been released.
Expert from the National Center for Immunization and Respiratory Diseases, a division of the CDC, discusses prevention strategies for group B streptococcus in infants, including the development of a maternal vaccine.
Mandated counseling to obtain a vaccine exemption was associated with a decrease in exemption rates and an increase in vaccine coverage.
The new adjuvanted herpes zoster subunit vaccine was more efficacious and less expensive for all ages at the price of $280 per series as compared to the single-dose herpes zoster vaccine.
A dedicated research effort led by NIH's National Institute of Allergy and Infectious Diseases is aimed at developing a universal influenza vaccine that would confer better and longer-lasting protection against influenza virus strains.
Primary care providers will play an important role in preventing the next wave of HIV infections.
Short-term use of probiotics appears to be safe and effective when used along with antibiotics in patients who are not immunocompromised or severely debilitated.
Two trials assessing different vaccination schedules and delivery methods for Zika virus vaccine reveal the vaccines to be safe, well tolerated, and immunogenic.
Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based educational interventions directly prevent HIV/STIs.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Major Advances on Horizon for Tick-Borne Disease Testing
- Measles Vaccination After Third Dose of DTP Vaccine May Improve Child Survival
- Vegetation Size May Increase Mortality Risk in Infective Endocarditis
- FDA Approves Blood Screens for Tickborne Parasite
- Effect of Vaccine Antigen Exposure in First 23 Months of Life
- Substantial Variation in HIV Diagnoses Among Persons Aged 13 to 29 Years
- Obesity, Older Age, and Pretreatment Cirrhosis Delay Fibrosis Improvements in HCV
- Oseltamivir Does Not Increase Suicide Risk in Pediatric Population
- Hepatitis C Eradication With DAAs Improves Carotid Atherosclerosis
- CDC Reports Number of Noncongenital Zika Virus Cases in the United States